HIV News and Research

RSS

Many preventive medical services cost patients nothing. Will a Texas court decision change that?

A federal judge's ruling in Texas has thrown into question whether millions of insured Americans will continue to receive some preventive medical services, such as cancer screenings and drugs that protect people from HIV infection, without making a copayment.

9 Sep 2022

COVID-19’s long-term impact on orphanhood and caregiver loss

Researchers performed epidemiologic modeling to update COVID-19-associated caregiver and parent loss estimates.

9 Sep 2022

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

Researchers explored probable humoral immune mechanisms related to EBV curtailment, besides neutralization, by a systematic emphasis on antibody fragment crystallizable-functional activities over the course of EBV infections.

9 Sep 2022

Promising anti-cancer agent may also prevent SARS-CoV-2 from replication

Based on findings from a new study by a Johns Hopkins Medicine-led research team, an effective means of fighting SARS-CoV-2, the virus that causes COVID-19, may be possible that circumvents the problem of waning immunity often observed when current vaccines deal with emerging COVID variants.

8 Sep 2022

SARS-CoV-2 infection leaves significant effects long after the patient is symptom-free

The immune cells of patients who received hospital care for COVID-19 early in the pandemic were still affected six months later.

8 Sep 2022

Recent literature reports on the role of the gut microbiome on human health and its effect on diseases

Researchers assessed the role of the gut microbiome in human health and disease.

8 Sep 2022

Study indicates that HIV-infected and uninfected patients have similar monkeypox illness outcomes

In a recent study published in the journal HIV Medicine, German researchers evaluated the clinical characteristics of Monkeypox virus (MPXV) infections in people with and without human immunodeficiency virus (HIV) infection.

7 Sep 2022

The virology, epidemiology, transmission, clinical manifestations, diagnosis, management, and prevention strategies associated with monkeypox

Scientists have described the epidemiology, transmission, clinical features, diagnosis, treatment, and preventive strategies of monkeypox infection among humans.

6 Sep 2022

Researchers present their viewpoint on the link between EBV infections and the development of MS based on a previous study

Researchers presented their viewpoint on the link between Epstein-Barr virus infections and the development of multiple sclerosis based on a previous study conducted by Bjornevik et al. published in Science.

6 Sep 2022

Meet Mary Wakefield, the nurse administrator tasked with revamping the CDC

It’s been a rough couple of years for the Centers for Disease Control and Prevention. Facing a barrage of criticism for repeatedly mishandling its response to the covid-19 pandemic and more recently monkeypox, the agency has acknowledged it failed and needs to change.

6 Sep 2022

What is currently known about the mechanism and treatments of long COVID?

The current understanding of the mechanisms underlying long COVID or post-acute sequelae of COVID and potential treatment methods that show promise in long COVID management.

6 Sep 2022

Monkeypox infection causing acute myocarditis - case report

A recent case report published in the journal JACC Case Reports indicated that monkeypox infection might be associated with acute myocarditis or heart muscle inflammation.

5 Sep 2022

Cellulitis, a deep bacterial infection of the skin, as a monkeypox complication

Researchers described two cases of human monkeypox and deep skin infection.

5 Sep 2022

Alternative approaches to functional and phenotypic assays using multi-parameter flow cytometry

Synexa is an industry-leading biomarker and large molecule bio analytic research service provider. In this interview, NewsMedical speaks with Natalie Strickland, a principal scientist at Synexa, about alternative approaches to flow cytometry.

From Synexa Life Sciences BV 5 Sep 2022

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

Dolutegravir-based antiretroviral therapies (ART) for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a study led by Harvard T.H. Chan School of Public Health researchers.

1 Sep 2022

What lessons can we learn from the COVID-19 pandemic for HIV?

A new study discussed how experiences from the coronavirus disease 2019 (COVID-19) pandemic could be leveraged for human immunodeficiency virus (HIV).

31 Aug 2022

The currently available evidence on viral-induced parkinsonism

A new review attempts to summarize all known about the relationship between viral illness and parkinsonian disorders to facilitate further research.

31 Aug 2022

State-level economic policy associated with reduction in HIV risk behavior among single mothers

UCLA research finds that a refundable State-level Earned Income Tax Credit (SEITC) of 10% or above the Federal EITC was associated with a 21% relative risk reduction in reported behavior that could put single mothers at high risk for becoming infected with HIV during the previous year.

30 Aug 2022

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

Researchers assessed the impact of SARS-CoV-2 ORF-6 on innate immune signaling.

30 Aug 2022

UK survey reveals outlook of the public towards health information circulating during the 2022 monkeypox virus outbreak

In new research, researchers explored the understanding and acceptance of public health messages about the monkeypox virus (MPXV) in the United Kingdom (UK).

30 Aug 2022

HIV News and Research

Many preventive medical services cost patients nothing. Will a Texas court decision change that?

COVID-19’s long-term impact on orphanhood and caregiver loss

The evolution of humoral immune responses over the course of Epstein-Barr virus infection

Promising anti-cancer agent may also prevent SARS-CoV-2 from replication

SARS-CoV-2 infection leaves significant effects long after the patient is symptom-free

Recent literature reports on the role of the gut microbiome on human health and its effect on diseases

Study indicates that HIV-infected and uninfected patients have similar monkeypox illness outcomes

The virology, epidemiology, transmission, clinical manifestations, diagnosis, management, and prevention strategies associated with monkeypox

Researchers present their viewpoint on the link between EBV infections and the development of MS based on a previous study

Meet Mary Wakefield, the nurse administrator tasked with revamping the CDC

What is currently known about the mechanism and treatments of long COVID?

Monkeypox infection causing acute myocarditis - case report

Cellulitis, a deep bacterial infection of the skin, as a monkeypox complication

Alternative approaches to functional and phenotypic assays using multi-parameter flow cytometry

Dolutegravir-based regimen more effective for treating pregnant people with HIV-1

What lessons can we learn from the COVID-19 pandemic for HIV?

The currently available evidence on viral-induced parkinsonism

State-level economic policy associated with reduction in HIV risk behavior among single mothers

Novel mechanism identified that SARS-CoV-2 uses to suppress antiviral responses to make the cell more permissive to infection

UK survey reveals outlook of the public towards health information circulating during the 2022 monkeypox virus outbreak

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News